Cargando…
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer
The EGFR R521K polymorphism has been shown to reduce the activity of EGFR; however, the association between EGFR R521K polymorphism and the risk of cancer remains inconclusive; therefore we performed a meta-analysis to evaluate the relationship between EGFR R521K polymorphism and susceptibility to c...
Autores principales: | Wang, Yinsheng, Zha, Lidan, Liao, Dan, Li, Xiaozhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221867/ https://www.ncbi.nlm.nih.gov/pubmed/25401099 http://dx.doi.org/10.1155/2014/312102 |
Ejemplares similares
-
The Relations between EGFR R521K Polymorphism and Risk of Cancer: Need for Clarification of Data in a Recent Meta-Analysis
por: Jiang, Jianjun, et al.
Publicado: (2015) -
EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer
por: Cserepes, Mihály, et al.
Publicado: (2022) -
Genetic Polymorphisms in the EGFR (R521K) and Estrogen Receptor (T594T) Genes, EGFR and ErbB-2 Protein Expression, and Breast Cancer Risk in Tunisia
por: Kallel, Imen, et al.
Publicado: (2009) -
Allele Frequencies of the Epidermal Growth Factor Receptors Polymorphism R521K in Colorectal Cancer Patients and Healthy Subjects Indicate a Risk-Reducing Effect of K521 in Syrian Population
por: Mustafa, Ola Haj, et al.
Publicado: (2013) -
Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk: A Meta-Analysis of Case–Control Studies
por: Hou, Qingtao, et al.
Publicado: (2015)